Academic Journals Database
Disseminating quality controlled scientific knowledge

Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line

Author(s): Stiefelhagen Marius | Sellner Leopold | Kleinschmidt Jürgen | Jauch Anna | Laufs Stephanie | Wenz Frederik | Zeller W Jens | Fruehauf Stefan | Veldwijk Marlon

Journal: Genetic Vaccines and Therapy
ISSN 1479-0556

Volume: 6;
Issue: 1;
Start page: 12;
Date: 2008;
Original page

Abstract Background For many promising target cells (e.g.: haematopoeitic progenitors), the susceptibility to standard adeno-associated viral (AAV) vectors is low. Advancements in vector development now allows the generation of target cell-selected AAV capsid mutants. Methods To determine its suitability, the method was applied on a chronic myelogenous leukaemia (CML) cell line (K562) to obtain a CML-targeted vector and the resulting vectors tested on leukaemia, non-leukaemia, primary human CML and CD34+ peripheral blood progenitor cells (PBPC); standard AAV2 and a random capsid mutant vector served as controls. Results Transduction of CML (BV173, EM3, K562 and Lama84) and AML (HL60 and KG1a) cell lines with the capsid mutants resulted in an up to 36-fold increase in CML transduction efficiency (K562: 2-fold, 60% ± 2% green fluorescent protein (GFP)+ cells; BV173: 9-fold, 37% ± 2% GFP+ cells; Lama84: 36-fold, 29% ± 2% GFP+ cells) compared to controls. For AML (KG1a, HL60) and one CML cell line (EM3), no significant transduction (
Why do you need a reservation system?      Affiliate Program